R&D expense · 2017–2025
Health Catalyst R&D expense
$49.8M−14.1% · FY2025
Health Catalyst (HCAT) reported $49.8M in R&D expense for fiscal 2025, −14.1% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $49.8M | −14.1% | Open → |
| FY20242024-12-31 | $58.0M | −20.2% | Open → |
| FY20232023-12-31 | $72.6M | −4.0% | Open → |
| FY20222022-12-31 | $75.7M | +20.6% | Open → |
| FY20212021-12-31 | $62.7M | +17.2% | Open → |
| FY20202020-12-31 | $53.5M | +15.7% | Open → |
| FY20192019-12-31 | $46.3M | +19.8% | Open → |
| FY20182018-12-31 | $38.6M | +35.6% | Open → |
| FY20172017-12-31 | $28.5M | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +7.2%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Health Catalyst R&D expense |url=https://companiesranked.com/en/company/health-catalyst/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Health Catalyst R&D expense. CompaniesRanked. https://companiesranked.com/en/company/health-catalyst/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-health-catalyst-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Health Catalyst R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/health-catalyst/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001636422-26-000035 · March 12, 2026
{{cite web |title=Health Catalyst R&D expense — 10-K (0001636422-26-000035) |url=https://www.sec.gov/Archives/edgar/data/1636422/000163642226000035/hcat-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-12}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.